PIERRE, S.D. (AP) — South Dakota state government and consumers will receive more than $548,000 from a 48-state settlement with a drug company accused of anti-competitive practices.

South Dakota Attorney General Marty Jackley says the state’s share of the settlement with drug maker Cephalon and affiliated companies will include about $189,000 for consumers, about $239,000 to compensate for drug purchases made by state entities or under state contracts and almost $310,000 for other state costs.

The settlement ends a multistate investigation into conduct by Cephalon that authorities say delayed generic versions of Provigil from entering the market for several years, causing consumers to pay higher prices. Provigil is used to help improve wakefulness for people with sleep disorders.

The company denied wrongdoing.

The 48-state settlement totaled $125 million.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!